NOX.AX · NOXOPHARM LIMITED
Australia · RS rating 15 · As of 2026-10-14
| Price | 0.05 AUD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 7 / 11 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 19 / 18 / 2 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +47.6% |
| Market cap (USD) | $13.0M |